You are here

Aerosol Ionization Mass Spectrometer (AIMS)

Award Information
Agency: Department of Defense
Branch: Office for Chemical and Biological Defense
Contract: W911-NF-22-P-0013
Agency Tracking Number: C212-003-0075
Amount: $167,494.29
Phase: Phase I
Program: SBIR
Solicitation Topic Code: CBD212-003
Solicitation Number: 21.2
Solicitation Year: 2021
Award Year: 2022
Award Start Date (Proposal Award Date): 2021-11-10
Award End Date (Contract End Date): 2022-05-31
Small Business Information
1891 N Gaffey St Ste 224
San Pedro, CA 90731-1270
United States
DUNS: 079397155
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 David Rodham
 (310) 935-2206
Business Contact
 Alex Kolessov
Phone: (310) 935-2206
Research Institution

There is an urgent need to rapidly test warfighters and their surrounding environment for disease-causing pathogens such as SARS-CoV-2. Existing methods for identifying pathogens in people usually require significant time and sample preparation. In addition, detecting pathogens such as SARS-CoV-2 in the air presents an even greater challenge. To meet the DoD need for field portable bioaerosol identification via mass spectrometry that can detect pathogens in the breath of warfighters and in the surrounding air, Hedgefog Research Inc. proposes to develop an Aerosol Ionization Mass Spectrometer (AIMS). The AIMS device will be a single aerosol particle mass spectrometer that will search for mass spectrometric evidence of pathogens on individual atmospheric aerosol particles. The AIMS device will also use the laser induced fluorescence from the aerosol particles to provide additional evidence for the presence of biomolecules. In Phase I HFR will demonstrate the feasibility of the AIMS technology. Additionally, in Phase I HFR will design a full-scale prototype for Phase II manufacture and testing.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government